Pathogenesis of enterotropic mouse hepatitis virus in immunocompetent and immunodeficient mice

Susan R Compton1, Lisa J Ball-Goodrich, Linda K Johnson

  • 1Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8016, USA.

Comparative Medicine
|February 1, 2005
PubMed

Insights

Mouse hepatitis virus (MHV) infection in mice shows B cells aid viral clearance from the gut. T cells are crucial for preventing MHV-Y spread beyond the gastrointestinal tract, avoiding lethal outcomes.

Area of Science:

  • Virology
  • Immunology
  • Pathogenesis

Background:

  • Mouse hepatitis virus (MHV) is a common pathogen in laboratory mice.
  • Enterotropic MHV strains frequently cause natural infections.
  • Understanding MHV pathogenesis in different immune contexts is vital for animal research.

Purpose of the Study:

  • To compare the pathogenesis of enterotropic MHV-Y in immunocompetent mice versus B and T cell-deficient mice.
  • To elucidate the roles of B and T cells in controlling MHV infection and dissemination.

Main Methods:

  • In situ hybridization to identify virus replication sites.
  • Reverse transcriptase-polymerase chain reaction (RT-PCR) to detect viral RNA in blood and feces.
  • Comparative study in BALB/c, C57BL/6, B cell-deficient, and T cell-deficient mice.

Main Results:

  • Immunocompetent mice experienced acute, subclinical gastrointestinal infections.
  • B cell-deficient mice developed chronic gastrointestinal infections lasting 7-8 weeks.
  • T cell-deficient mice succumbed to lethal, multisystemic infections with viral spread beyond the gut.

Conclusions:

  • B cells contribute to the clearance of MHV-Y from the intestinal mucosa.
  • T cells are essential for preventing MHV-Y dissemination from the gastrointestinal tract and lymphoid tissues.
  • Immune cell deficiencies significantly alter MHV pathogenesis, leading to chronic or lethal outcomes.

Related Concept Videos